Format

Send to:

Choose Destination
See comment in PubMed Commons below
Gastroenterol Hepatol (N Y). 2011 Jan;7(1):16-24.

Updates in the management of hepatocellular carcinoma.

Author information

  • 1Department of Medicine at California Pacific Medical Center in San Francisco, California, USA. wongrz@sutterhealth.org

Abstract

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death, and its increasing incidence worldwide is a cause for concern. Fortunately, advances in diagnostic and therapeutic approaches have contributed to earlier detection and treatment. As cancer epidemiology studies continue to elucidate the natural history of liver diseases, greater understanding of HCC has led to improved risk stratification and earlier enrollment of high-risk patients in cancer screening and surveillance programs. Improved survival rates among HCC patients also reflect significant advances in available treatment options. Advances in surgical techniques are pushing the boundaries of resection for localized disease, and progress in the field of transplantation has led to refinements in listing criteria and improved post-transplantation outcomes. The evolving field of locoregional therapies-including percutaneous ablation and transarterial chemoembolization-continues to provide novel therapeutic options that can be used in place of, or in addition to, surgical approaches. Recent advances in systemic multikinase inhibitor therapies have also demonstrated significant benefits for advanced-stage disease, and these therapies also show promise as adjuvant treatments for earlier-stage disease. This article provides an update on the management of HCC, with a focus on revised guidelines for screening and an in-depth discussion of emerging novel therapies.

KEYWORDS:

Cancer screening and surveillance; chemoembolization; liver cancer staging; locoregional therapy; radiofrequency ablation; sorafenib; yttrium-90

PMID:
21346848
[PubMed]
PMCID:
PMC3038312
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk